These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27863006)

  • 1. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
    Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
    J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin.
    Chowdhury S; Wang X; Srikant CB; Li Q; Fu M; Gong YJ; Ning G; Liu JL
    Endocrinology; 2014 May; 155(5):1629-42. PubMed ID: 24552398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival
    Kaddour N; Zhang D; Gao ZH; Liu JL
    Growth Factors; 2019 Aug; 37(3-4):120-130. PubMed ID: 31437074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
    Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
    Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
    Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Effects of CCN5/WISP2 Gene Deficiency and Transgenic Overexpression in Mice.
    Alami T; Liu JL
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
    Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
    BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt1 inducible signalling pathway protein-2 (WISP‑2/CCN5): roles and regulation in human cancers (review).
    Ji J; Jia S; Ji K; Jiang WG
    Oncol Rep; 2014 Feb; 31(2):533-9. PubMed ID: 24337439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells.
    Minchenko DO; Kharkova AP; Tsymbal DO; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2015 Oct; 49(4):185-97. PubMed ID: 26494037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
    Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
    Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells.
    Haque I; Banerjee S; Mehta S; De A; Majumder M; Mayo MS; Kambhampati S; Campbell DR; Banerjee SK
    J Biol Chem; 2011 Dec; 286(50):43475-85. PubMed ID: 22020939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
    Ferrand N; Stragier E; Redeuilh G; Sabbah M
    Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
    Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
    J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
    Sun S; Cui Z; Yan T; Wu J; Liu Z
    Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT.
    Grünberg JR; Hammarstedt A; Hedjazifar S; Smith U
    J Biol Chem; 2014 Mar; 289(10):6899-6907. PubMed ID: 24451367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
    Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
    Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wisp2/CCN5 up-regulated in the central nervous system of GM3-only mice facilitates neurite formation in Neuro2a cells via integrin-Akt signaling.
    Ohkawa Y; Ohmi Y; Tajima O; Yamauchi Y; Furukawa K; Furukawa K
    Biochem Biophys Res Commun; 2011 Aug; 411(3):483-9. PubMed ID: 21723256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
    Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
    Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.